FY2026 · ended Jan 31, 2026 · Revenue $1.31B, +9.5% YoY · Filed Mar 17, 2026
Healthequity, Inc. (HQY) files with the SEC under industry code 7389, Services-Business Services, NEC. In fiscal 2026, which ended Jan 31, 2026, it reported revenue of $1.3 billion and net income of $215.2 million. Free cash flow was $455.1 million. As of Jul 31, 2026 it held $256.0 million in cash and investments and $971.0 million in total debt.
Revenue (TTM)
$1.36B
+7.3% vs year-ago TTM
Net income (TTM)
$236.49M
+62.2% vs year-ago TTM
Operating cash flow (TTM)
$490.18M
+33.6% vs year-ago TTM
Free cash flow (TTM)
$487.73M
+33.5% vs year-ago TTM
EPS (TTM)
$2.76
+67.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
84.48M
-2.3% vs prior year
Net cash
$-715.01M
as of Jul 31, 2026
Operating margin
25.8%
FY 2027
Company profile
- Industry
- Services-Business Services, NEC (SIC 7389)
- Listed as
- HQY (Nasdaq)
- Fiscal year ends
- January 31
- Incorporated in
- DE
- Headquarters
- Draper, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1428336
- Former names
- HEALTHEQUITY INC (until Jun 6, 2019)
Other Services-Business Services, NEC companies
- Visa Inc. V
- Mastercard Inc MA
- Alibaba Group Holding Ltd BABA
- Accenture plc ACN
- Uber Technologies, Inc UBER
- PDD Holdings Inc. PDD
- Mercadolibre Inc MELI
- DoorDash, Inc. DASH
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jan 31, 2026 |
FY 2025 Jan 31, 2025 |
FY 2024 Jan 31, 2024 |
FY 2023 Jan 31, 2023 |
FY 2022 Jan 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $999.6M | $861.7M | $756.6M |
| Operating income | $322.5M | $162.3M | $117.7M | $9.1M | -$24.2M |
| Net income | $215.2M | $96.7M | $55.7M | -$26.1M | -$44.3M |
| Diluted EPS | $2.46 | $1.09 | $0.64 | -$0.31 | -$0.53 |
| Operating cash flow | $457.1M | $339.9M | $242.8M | $150.7M | $141.0M |
| Free cash flow | $455.1M | $337.8M | $241.1M | $147.3M | $132.1M |
| Total assets | $3.4B | $3.4B | $3.2B | $3.1B | $3.1B |
| Total liabilities | $1.3B | $1.3B | $1.1B | $1.2B | $1.3B |
| Stockholders' equity | $2.1B | $2.1B | $2.0B | $1.9B | $1.9B |
| Cash and investments | $318.9M | $295.9M | $404.0M | $254.3M | $225.4M |
| Total debt | $1.0B | $1.1B | $933.1M | $994.5M | $1.0B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 9, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2026 | Sep 24, 2026 |
| 10-Q | Quarterly report | Aug 27, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 27, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2026 | Jun 25, 2026 |
| 10-Q | Quarterly report | May 28, 2026 | Apr 30, 2026 |
All 1003 Healthequity, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.